The model simulation showing that portosystemic shunting in NASH and NAFLD generates imbalances between splanchnic and systemic distributions of insulin, glucagon and GLP-1 relative to glucose that stimulate insulin-sensitive metabolism in both liver that leads to hyperglucagonaemia and low GLP-1 is novel. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.